Search Results - "Choy, Ernest"
-
1
Clinical significance of Janus Kinase inhibitor selectivity
Published in Rheumatology (Oxford, England) (01-06-2019)“…Cytokines are key drivers of inflammation in RA, and anti-cytokine therapy has improved the outcome of RA. Janus Kinases (JAK) are intracellular tyrosine…”
Get full text
Journal Article -
2
The role of sleep in pain and fibromyalgia
Published in Nature reviews. Rheumatology (01-09-2015)“…Key Points Abnormal pain processing is an important pathophysiological feature of fibromyalgia, and nonrestorative sleep is a common clinical and diagnostic…”
Get full text
Journal Article -
3
Transforming clinical trials in rheumatology: towards patient-centric precision medicine
Published in Nature reviews. Rheumatology (01-10-2020)“…Despite the success of targeted therapies in the treatment of inflammatory arthritides, the lack of predictive biomarkers drives a ‘trial and error’ approach…”
Get full text
Journal Article -
4
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities
Published in Seminars in arthritis and rheumatism (01-02-2021)“…•CRP is a valuable marker and regulator of systemic inflammation in RA.•CRP levels appear to be associated with common comorbidities of RA.•CRP appears to play…”
Get full text
Journal Article -
5
Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-11-2018)“…Abstract RA is a chronic, systemic, autoimmune disease characterized by inflammation and degradation of the joints, causing significant negative impact on…”
Get full text
Journal Article -
6
Cognitive behavioural therapies for fibromyalgia
Published in Cochrane database of systematic reviews (10-09-2013)“…Fibromyalgia (FM) is a clinically well-defined chronic condition of unknown aetiology characterized by chronic widespread pain that often co-exists with sleep…”
Get more information
Journal Article -
7
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-11-2019)“…Abstract Fatigue is a common and debilitating symptom in patients with RA. Since 2007, fatigue has been included as one of the core outcome measures in RA…”
Get full text
Journal Article -
8
Clinical significance of Janus Kinase inhibitor selectivity
Published in Rheumatology (Oxford, England) (01-06-2019)Get full text
Journal Article -
9
Non-pharmacological interventions for fatigue in rheumatoid arthritis
Published in Cochrane database of systematic reviews (23-08-2013)“…Fatigue is a common and potentially distressing symptom for people with rheumatoid arthritis with no accepted evidence based management guidelines…”
Get more information
Journal Article -
10
Biologic interventions for fatigue in rheumatoid arthritis
Published in Cochrane database of systematic reviews (06-06-2016)“…Fatigue is a common and potentially distressing symptom for patients with rheumatoid arthritis (RA), with no accepted evidence-based management guidelines…”
Get more information
Journal Article -
11
Translating IL-6 biology into effective treatments
Published in Nature reviews. Rheumatology (01-06-2020)“…In 1973, IL-6 was identified as a soluble factor that is secreted by T cells and is important for antibody production by B cells. Since its discovery more than…”
Get full text
Journal Article -
12
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Published in Annals of the rheumatic diseases (01-01-2021)“…Rheumatic and musculoskeletal immune-related adverse events (irAEs) are observed in about 10% of patients with cancer receiving checkpoint inhibitors (CPIs)…”
Get more information
Journal Article -
13
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
Published in Seminars in arthritis and rheumatism (01-02-2021)“…Pain is a manifestation of rheumatoid arthritis (RA) that is mediated by inflammatory and non-inflammatory mechanisms and negatively affects quality of life…”
Get full text
Journal Article -
14
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis
Published in Cochrane database of systematic reviews (15-08-2012)“…Idiopathic inflammatory myopathies are chronic diseases with significant mortality and morbidity. Whilst immunosuppressive and immunomodulatory therapies are…”
Get more information
Journal Article -
15
Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and Fibrosis
Published in Journal of Scleroderma and Related Disorders (2017)“…Interleukin 6 (IL-6) is a 184-amino acid protein cytokine that is produced by many types of cells and is expressed during states of cellular stress, such as…”
Get full text
Book Review Journal Article -
16
Residual pain in rheumatoid arthritis: Is it a real problem?
Published in Autoimmunity reviews (01-11-2023)Get full text
Journal Article -
17
-
18
Fatigue in rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-11-2019)Get full text
Journal Article -
19
Using biologics safely
Published in Rheumatology (Oxford, England) (01-09-2019)Get full text
Journal Article -
20
Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide
Published in Clinical gastroenterology and hepatology (01-03-2022)“…Herpes zoster is a painful dermatomal cutaneous eruption resulting from reactivation of the latent varicella–zoster virus. Patients with inflammatory bowel…”
Get full text
Journal Article